Form 4 for CRL Charles River Laboratories
Accepted 2022-08-08 00:00:00 ET · period of report 2022-07-06 · accession 0001127602-22-020666 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-08 | 2022-08-05 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $226.13 | -200 | 20.8K | -1.0% | -$45.2K | |
| 2022-08-08 | 2022-07-06 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -195 | 21.0K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | S | D | 200 | $226.13 | 20,766 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-06 | G | D | 195 | $0.00 | 20,966 | D | — | — |